...
首页> 外文期刊>Analytical methods >GC analysis of guanidino compounds in serum and urine of healthy volunteers and uremic patients using methylglyoxal and ethyl chloroformate as derivatizing reagent
【24h】

GC analysis of guanidino compounds in serum and urine of healthy volunteers and uremic patients using methylglyoxal and ethyl chloroformate as derivatizing reagent

机译:以甲基乙二醛和氯甲酸乙酯为衍生试剂对健康志愿者和尿毒症患者血清和尿中胍基化合物进行GC分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Gas chromatographic (GC) determination of 9 guanidino compounds: guanidine, methylguanidine, guanidinoacetic acid, guanidinopropionic acid, guanidinobutyric acid, guanidinosuccinic acid, arginine, creatinine and creatine have been examined from the serum and urine of healthy volunteers and uremic patients using precolumn derivatization with methylglyoxal and ethyl chloroformate. GC elution and separation was from the column HP-5 (30 m x 0.32 mm id) with film thickness 0.25 mu m within 10.5 min. The detection was carried out using FID. The linear calibration curves for guanidino compounds were within 0.1-20.0 mu molL(-1) and the lower limits of detection were 0.014-0.027 mu mol L-1. The amounts of guanidino compounds observed in the serum of healthy volunteers were 0.2-88.0 mu mol L-1 as compared to that of uremic patients at 0.8-521 mu mol L-1, with relative standard deviations (RSDs) within 1.5-3.7% and 1.0-3.8%, respectively. The guanidino compounds in the urine of healthy volunteers and uremic patients were observed in the range below the limit of detection (BLOD) to 7304 mu mol L-1 and below LOD -7541 mu mol L-1, with RSDs 1.1-3.7% and 1.0-3.8%, respectively. The derivatization, separation and quantitation were repeatable with RSD <4%. Recovery of the guanidino compounds calculated by standard addition from serum and urine was obtained within 93-105% and 89-99%, with RSDs 1.4-2.9% and 1.8-4.3%, respectively.
机译:气相色谱法(GC)测定了健康志愿者和尿毒症患者的血清和尿液中9种胍基化合物:胍,甲基胍,胍基乙酸,胍基丙酸,胍基丁酸,胍基琥珀酸,精氨酸,肌酐和肌酸。甲基乙二醛和氯甲酸乙酯。 GC洗脱和分离来自HP-5色谱柱(内径30 m x 0.32 mm),在10.5分钟内膜厚度为0.25μm。使用FID进行检测。胍基化合物的线性校准曲线在0.1-20.0μmolL-1范围内,检测下限为0.014-0.027μmolL-1。健康志愿者血清中观察到的胍基化合物的量为0.2-88.0μmolL-1,而尿毒症患者的胍基化合物的量为0.8-521μmolL-1,相对标准偏差(RSD)在1.5-3.7%之内和1.0-3.8%。在健康志愿者和尿毒症患者的尿液中观察到胍基化合物的范围低于检出限(BLOD)至7304μmolL-1,低于LOD -7541μmolL-1,相对标准偏差为1.1-3.7%,分别为1.0-3.8%。 RSD <4%时,可重复进行衍生,分离和定量。通过标准添加从血清和尿液中计算得到的胍基化合物的回收率分别在93-105%和89-99%之间,RSD分别为1.4-2.9%和1.8-4.3%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号